首页
  大会概况
  大会组委会
  会议议程
  卫星会议议程
  大会议程
  社会活动
  大会展览
  大会赞助
  壁报展示
  大会注册
  酒店预定
  乘车路线
  联系我们
大会议程

Friday 31st of August 2007

09:00-18:00
PHARMACEUTICAL MANUFACTURING SCIENCE & PRACTICE
FIP/CPA JOINT WORKSHOPS

R1


09:00-17:00
PRE-SATELLITE WORKSHOP:
STRATEGIES IN MEDICATION SAFETY –
PHARMACOVIGILANCE AND PREVENTING MEDICATION ERRORS

R2*

Saturday 1st of September 2007

09:00-18:00

 

 
 

09:00-17:00

PRE-SATELLITE WORKSHOP:
STRATEGIES IN MEDICATION SAFETY –
PHARMACOVIGILANCE AND PREVENTING MEDICATION ERRORS

R2*

09:00-14:00

INTRODUCTION TO CHINESE PHARMACY PRACTICE
R3*

13:00-17:00

FORUM FOR INNOVATORS IN PHARMACY PRACTICE
Pharmacist advice at the counter – Implementation of Best Practice Standards

R4*



Sunday 2nd of September 2007

09:00-12:30

FORUM FOR INNOVATORS IN PHARMACY PRACTICE
Pharmacist advice at the counter – Implementation of Best Practice Standards

R4*

Monday 3rd of September 2007

09:00-18:00

FIP SPECIAL INTEREST GROUP MEETINGS

09:00-17:00

ANTIMICROBIAL DRUG RESISTANCE – THE ROLE OF THE PHARMACY PROFESSION IN TACKLING THIS EMERGING GLOBAL HEALTH PROBLEM
G25*
PHARMACEUTICAL DISTINCTIVE FEATURES OF DIFFERENT COUNTRIES DURING THEIR HISTORY

09:00-12:00

FIP/IPSF STUDENTS’ DAY:
SOCIAL DIMENSIONS OF DEVELOPING THE PHARMACY PROFESSION

G9*
DISSOLUTION TESTING: A PIVOTAL TOOL FOR DEVELOPMENT AND QUALITY OF DRUGS
S1
PERSONAL, CULTURAL AND SOCIAL BELIEF SYSTEMS AND THE USE OF MEDICINES
P1*
LIFE LONG LEARNING AND CONTINUING PROFESSIONAL DEVELOPMENT: WE HAVE ALL HEARD THE THEORY, WHAT IS THE EVIDENCE?
G1*
PHARMACEUTICALS AND THE ENVIRONMENT
G17*
WORKSHOP: NUCLEAR/RADIOLOGIC PHARMACY
G33

13:00-16:00

FINANCING THE HEALTHCARE
G10*
PHARMACOEPIDEMIOLOGY: (a) HEPATITIS MODEL & (b) ANTIBIOTIC RESISTANCE
S2
BPP/BPS JOINT SYMPOSIUM (PART I)

EXPERIENTIAL LEARNING –
BRIDGING CLASSROOM EDUCATION AND PHARMACY PRACTICE

G2*
HOW TO GUARANTEE THE BEST THERAPEUTIC OUTCOME OF A PHARMACEUTICAL PRODUCT – THE INFLUENCE OF A LIFE CYCLE
G18*
RISK COMMUNICATION IN PATIENT SAFETY: TO WHAT EXTENT CAN PICTOGRAMS HELP IN LABELING?
G26*
CLINICAL BIOLOGY IN SOUTH EAST ASIA
G34*


Tuesday 4th of September 2007

09:00-12:00

TRENDS IN COMMUNITY PHARMACY – DEBATING THE FUTURE OF THE PROFESSION: FORUM FOR POLICY MAKERS IN PHARMACY PRACTICE
G11*
IMPROVING BIOAVAILABILITY/BIOEQUIVALENCE
S3
REGULATORY, MANUFACTURING, SUPPLY-CHAIN AND QUALITY STANDARDS ISSUES
P2*
EVIDENCE BASED PRACTICE AND COMPLEMENTARY MEDICINES: TEACHING AND LEARNING BY EXAMPLE
G3*
CLINICAL TRIALS IN ASIA
G19*
CUSTOMER RELATIONSHIPS (PART I)
G27*
EVOLUTION OF PRACTICES IN CLINICAL BIOLOGY
G35*

12:30-13:30

FLU PANDEMIC PROGRAMME (PART I)

13:00-16:00

CURBING THE TOBACCO PANDEMIC – THE ROLE OF THE PHARMACIST
This session was made possible via an educational grant from Johnson & Johnson


STEERING COMMITTEE MEETING
G12

BIOTECHNOLOGY
S4
BPP/BPS JOINT SYMPOSIUM (PART II)

IS THERE ENOUGH EVIDENCE FOR THE VALUE OF PHARMACISTS?
G4*
CUSTOMER RELATIONSHIPS (PART II)
G28*
NANOTECHNOLOGY – FROM SCIENCE TO INDUSTRIAL PRACTICE
G36

Wednesday 5th of September 2007

09:00-12:00

PRACTITIONERS’ DAY – SHORT ORAL PRESENTATIONS (FORUM I – PART I)
G13
QUALITY CONTROL FOR NATURAL PRODUCTS
S5
TECHNICAL, SCIENTIFIC AND EVIDENCE-BASED INFORMATION RESOURCES ABOUT MEDICINES
P3*
SHORT ORAL PRESENTATIONS
G5
PRACTITIONERS’ DAY – SHORT ORAL PRESENTATIONS ( FORUM II - PART I)
G21
WHO/FIP WORKSHOP:
HERBAL MEDICINES: EDUCATION AND TRAINING OF PHARMACY PRACTITIONERS

G23
MEDICATION REVIEWS – FROM MEDICATION COUNSELLING TOWARDS SERVICE DELIVERY
G29*
SHORT ORAL PRESENTATIONS (PART I):
MANUFACTURING AND GOOD MANUFACTURING PRACTICE

G37

12:30-13:30

FLU PANDEMIC PROGRAMME (PART II)

13:00-16:00

PRACTITIONERS’ DAY – SHORT ORAL PRESENTATIONS (FORUM I - PART II)
G14
RESEARCH IN NATURAL PRODUCTS
S6
FUTURE ISSUES WITH CONVENTIONAL, AND COMPLEMENTARY & ALTERNATIVE MEDICINES
P4*
STRENGTHENING THE REPONSIBLE SELF CARE OF PATIENTS
G6*
PRACTITIONERS’ DAY – SHORT ORAL PRESENTATIONS (FORUM II - PART II)
G22
GOOD VERSUS BAD DRUG INFORMATION IN THE PUBLIC DOMAIN – CAN YOU SPOT THE DIFFERENCE?
Empowering pharmacists and educating patients how to use online information

G30*
SHORT ORAL PRESENTATIONS (PART II):
DRUG DELIVERY

G38


Thursday 6th of September 2007

09:00-12:30
CONTINUING EDUCATION PROGRAMME:
FROM RESEARCH TO DAILY PRACTICE – IMPLEMENTING “FAMILY PHARMACY” – AN INNOVATIVE STRATEGY AND BUSINESS MODEL

(PART I)


G15*

09:00-12:00

IMPACT OF INDIVIDUALISED MEDICINE IN PHARMACEUTICAL CARE
S7
THE ASIAN DRUG MARKET – CURRENT TOPICS AND CHALLENGES
G7*
THE USE OF INFORMATICS TO IMPROVE MEDICATION SAFETY
G31*
RATIONALISING MEDICATION MANAGEMENT FOR EMERGENCY RESPONSE
G39*

13:00-16:00

CONTINUING EDUCATION PROGRAMME: FROM RESEARCH TO DAILY PRACTICE –
IMPLEMENTING “FAMILY PHARMACY” – AN INNOVATIVE STRATEGY AND BUSINESS MODEL (PART II)

G16*
CHEMICAL BIOLOGY
S8
THE CHALLENGES OF DIABETES IN ASIA
G8*
GOOD MANUFACTURING PRACTICE (GMP) & GOOD CLINICAL PRACTICE (GCP)
G24
CURRENT ISSUES ON DRUG AND HEALTHCARE INFORMATION
G32
RESPONDING TO GLOBAL AND LOCAL EMERGENCIES
G40*